Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 08 Jun 2023 for Satsuma Pharmaceuticals, Inc., €18.8M. Read the official filing
Filing timeline
BuySaleShin Nippon Biomedical Laboratories, Ltd.
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Shin Nippon Biomedical Laboratories, Ltd.: trading record in brief
One trade, one date: on 8 June 2023, Shin Nippon Biomedical Laboratories, Ltd. disclosed an open-market purchase of €18.8M in Satsuma Pharmaceuticals, Inc. No broader history exists yet. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Shin Nippon Biomedical Laboratories, Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
22,053,581 shares@ US$0.91100.0% of flowCommon StockSEC:0000899243-23-014866:0
Canonical exit: 4 Sept 2023 (T+90)
1 of 1 declaration
